Prognosis of vasculitis associated myelodysplasia

C Belizna; J F Subra; D Henrion; A Ghali; G Renier; M Royer; Y Le Corre; L Martin; J Voswinkel; N Ifrah

doi:10.1016/j.autrev.2013.01.005

Prognosis of vasculitis associated myelodysplasia

Autoimmun Rev. 2013 Aug;12(10):943-6. doi: 10.1016/j.autrev.2013.01.005. Epub 2013 Mar 28.

Authors

C Belizna¹, J F Subra, D Henrion, A Ghali, G Renier, M Royer, Y Le Corre, L Martin, J Voswinkel, N Ifrah

Affiliation

¹ Internal Medicine Department, University Hospital Angers, 4 rue Larey, France. [email protected]

PMID: 23542504
DOI: 10.1016/j.autrev.2013.01.005

Abstract

Systemic and immune manifestations have been reported in patients with MDS. The correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients remains controversial. Most of the authors agree that the median survival in myelodysplastic syndrome is not related to the presence of systemic and immune manifestations, but only with the existence of a systemic vasculitis.

Keywords: Malignancy; Myelodysplasia; Prognosis; Vasculitis.

Publication types

Review

MeSH terms

Humans
Myelodysplastic Syndromes / complications*
Myelodysplastic Syndromes / immunology
Myelodysplastic Syndromes / mortality*
Myelodysplastic Syndromes / physiopathology
Prognosis
Systemic Vasculitis / complications*
Systemic Vasculitis / immunology